{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:32:59Z","timestamp":1722904379017},"reference-count":26,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.neulet.2013.06.020","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T09:04:44Z","timestamp":1372151084000},"page":"97-102","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effect of blonanserin on methamphetamine-induced disruption of latent inhibition and c-Fos expression in rats"],"prefix":"10.1016","volume":"549","author":[{"given":"Aki","family":"Kuramashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Koganemaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisae","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichiro","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Nishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2013.06.020_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11202620-000000000-00000","article-title":"Blonanserin: a review of its use in the management of schizophrenia","volume":"24","author":"Deeks","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2013.06.020_bib0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","article-title":"The use of c-fos as a metabolic marker in neuronal pathway tracing","volume":"29","author":"Dragunow","year":"1989","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neulet.2013.06.020_bib0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0006-3223(91)90133-7","article-title":"The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats\u2019 ability to ignore irrelevant stimuli","volume":"29","author":"Feldon","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.06.020_bib0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00023210-200923070-00006","article-title":"The efficacy and safety of blonanserin compared with haloperidol in acute-phase schizophrenia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"23","author":"Garcia","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2013.06.020_bib0025","first-page":"820","article-title":"Antagonism of amphetamine-induced disruption of latent inhibition by the atypical antipsychotic olanzapine in rats","volume":"7","author":"Gosselin","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neulet.2013.06.020_bib0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbr.2013.03.027","article-title":"Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT partial agonism","volume":"247","author":"Horiguchi","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2013.06.020_bib0035","first-page":"135","article-title":"Long-term clinical study of blonanserin for schizophrenia (Japan-wide study)","volume":"11","author":"Kinoshita","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2013.06.020_bib0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1037\/h0034425","article-title":"Latent inhibition","volume":"79","author":"Lubow","year":"1973","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neulet.2013.06.020_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4236\/jbbs.2011.13022","article-title":"Effect of aripiprazole on methamphetamine-induced disruption of latent inhibition in rats","volume":"1","author":"Matsuo","year":"2011","journal-title":"J. Behav. Brain Sci."},{"key":"10.1016\/j.neulet.2013.06.020_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-4328(99)00022-4","article-title":"Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies","volume":"101","author":"McBride","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2013.06.020_bib0055","first-page":"845","article-title":"Dopamine-serotonin antagonist: receptor binding profile of a novel antipsychotics blonanserin","volume":"11","author":"Murasaki","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2013.06.020_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2010.11.025","article-title":"Reduced dopamine function within the medial shell of the nucleus accumbens enhances latent inhibition","volume":"98","author":"Nelson","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neulet.2013.06.020_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.11.023","article-title":"Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex","volume":"653","author":"Ohoyama","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2013.06.020_bib0070","first-page":"158","article-title":"Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties","volume":"264","author":"Oka","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2013.06.020_bib0075","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neulet.2013.06.020_bib0080","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/j.1460-9568.2005.04388.x","article-title":"Double dissociation of the effects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour and salience learning in rats","volume":"22","author":"Pothuizen","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2013.06.020_bib0085","first-page":"519","article-title":"Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder","volume":"16","author":"Solomon","year":"1981","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2013.06.020_bib0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/nlme.1995.1042","article-title":"Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats","volume":"64","author":"Tai","year":"1995","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neulet.2013.06.020_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0006-8993(01)02991-2","article-title":"Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain","volume":"919","author":"Thiriet","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2013.06.020_bib0100","first-page":"1263","article-title":"Pharmacological profile of blonanserin","volume":"10","author":"Une","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2013.06.020_bib0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF02244998","article-title":"Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron","volume":"114","author":"Warburton","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2013.06.020_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-002-1313-x","article-title":"The \u201ctwo-headed\u201d latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment","volume":"169","author":"Weiner","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2013.06.020_bib0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2009.05.004","article-title":"Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment","volume":"204","author":"Weiner","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2013.06.020_bib0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0166-4328(96)00051-4","article-title":"Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity","volume":"81","author":"Weiner","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2013.06.020_bib0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/sj.npp.1300069","article-title":"Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action","volume":"28","author":"Weiner","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2013.06.020_bib0130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0006-3223(95)00573-0","article-title":"The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine","volume":"40","author":"Weiner","year":"1996","journal-title":"Biol. Psychiatry"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013005673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013005673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T22:24:36Z","timestamp":1539555876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394013005673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":26,"alternative-id":["S0304394013005673"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2013.06.020","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of blonanserin on methamphetamine-induced disruption of latent inhibition and c-Fos expression in rats","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2013.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}